Yiqi Fumai injection in the treatment of chronic heart failure: an overview of systematic reviews_Chinese Journal of Evidence-Based Medicine

Authors：

FAN Maoxia ¹ ,  DAI Guohua ² , LI Runmin ¹ , REN Lili ¹

1. The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan 250014, P. R. China;
2. Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, P. R. China;

Corresponding author：

DAI Guohua, Email: daiguohua202208@163.com

Keywords：

Yiqi Fumai injection; Chronic heart failure; Overview of systematic reviews

DOI：

10.7507/1672-2531.202211057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To overview of systematic reviews (SRs) of Yiqi Fumai (YQFM) injection in the treatment of chronic heart failure (CHF). Methods The PubMed, Cochrane Library, EMbase, Web of Science, CNKI, CBM and WanFang Data databases were electronically searched to collect SRs of YQFM injection in the treatment of CHF from January 1, 2007 to October 31, 2022. Two reviewers independently screened literature, extracted data and assessed methodological quality, risk of bias, report quality and evidence quality by using AMSTAR-2, ROBIS scale, PRISMA, and GRADE system. Results A total of 7 SRs were included. The evaluation results showed that the quality of all SRs was low, a few SRs were assessed as having a low risk of bias, and all SRs were relatively completely reported. A total of 46 results were extracted from the included SRs, including 3 with moderate quality evidence, 12 with low quality evidence and 31 with very low quality evidence. Conclusion YQFM may be an effective and safe treatment, but current evidence quality is low.

Citation： FAN Maoxia, DAI Guohua, LI Runmin, REN Lili. Yiqi Fumai injection in the treatment of chronic heart failure: an overview of systematic reviews. Chinese Journal of Evidence-Based Medicine, 2023, 23(5): 569-574. doi: 10.7507/1672-2531.202211057 Copy

1.	中国中西医结合学会心血管疾病专业委员会, 中国医师协会中西医结合医师分会心血管疾病专业委员会. 慢性心力衰竭中西医结合诊疗专家共识. 心脑血管病防治, 2016, 16(5): 340-347.
2.	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint Committee on Clinical Practice Guidelines. Circulation, 2022, 145(18): e876-e894.
3.	褚延斌, 苏小琴, 李德坤, 等. 基于一测多评法对注射用益气复脉(冻干)中9种成分的质量控制研究. 中草药, 2017, 48(17): 3537-3544.
4.	孟静, 鲁晓燕. 注射用益气复脉(冻干)治疗心力衰竭的药理作用及临床应用研究进展. 药物评价研究, 2020, 43(8): 1506-1509.
5.	鞠爱春, 罗瑞芝, 苏小琴, 等. 注射用益气复脉(冻干)化学成分及质量控制研究进展. 药物评价研究, 2018, 41(3): 365-371.
6.	鞠爱春, 罗瑞芝, 秦袖平, 等. 注射用益气复脉(冻干)药理作用及临床研究进展. 药物评价研究, 2018, 41(3): 354-364.
7.	Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 2021, 372: n160.
8.	陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具AMSTAR 2解读. 中国循证医学杂志, 2018, 18(1): 101-108.
9.	吴琼芳, 丁泓帆, 邓围, 等. ROBIS: 评估系统评价偏倚风险的新工具. 中国循证医学杂志, 2015, 15(12): 1454-1457.
10.	Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
11.	连宝涛, 李泽彰, 陈嘉城, 等. 益气复脉注射液治疗心力衰竭的系统评价. 中国实验方剂学杂志, 2016, 22(8): 215-220.
12.	王贤良, 马宁, 侯雅竹, 等. 注射用益气复脉(冻干)联合西药常规治疗慢性心力衰竭疗效的Meta分析. 中医杂志, 2016, 57(5): 391-395.
13.	周丽, 范芳芳, 帕提古丽·阿卜杜力, 等. 益气复脉注射液治疗心力衰竭有效性和安全性的Meta分析. 中国医药导报, 2016, 13(22): 93-96,104.
14.	熊尧, 徐程, 陈嘉音, 等. 注射用益气复脉(冻干)治疗心力衰竭的Meta分析. 沈阳药科大学学报, 2017, 34(5): 428-435.
15.	谢娜, 戴小华. 注射用益气复脉(冻干)治疗心力衰竭疗效的Meta分析. 中西医结合心脑血管病杂志, 2019, 17(10): 1499-1503.
16.	Nie H, Li S, Liu M, et al. Yiqi Fumai injection as an adjuvant therapy in treating chronic heart failure: a meta-analysis of 33 randomized controlled trials. Evid Based Complement Alternat Med, 2020, 2020: 1876080.
17.	樊根豪, 邢作英, 刘梦琳, 等. 注射用益气复脉(冻干)治疗心力衰竭有效性及安全性的系统评价和试验序贯分析. 实用中医内科杂志, 2021, 35(1): 8-18.
18.	周国锋, 李媛, 林芮, 等. 中药注射剂治疗心力衰竭系统评价再评价. 中华中医药学刊, 2019, 37(1): 125-129.
19.	陈炜坚, 陈慕镟, 林挺, 等. 中药注射剂治疗心律失常的系统评价再评价. 中国医院药学杂志, 2020, 40(23): 2445-2452.
20.	黄帆, 赵思怡, 戴琳, 等. 运用雷达图对针灸治疗原发性骨质疏松症的系统评价再评价. 中国循证医学杂志, 2019, 19(5): 602-608.
21.	杨继, 张垚, 高晟玮, 等. 麝香保心丸治疗冠心病心绞痛系统评价的再评价. 中国中医急症, 2021, 30(5): 785-789.
22.	刘亦琳, 徐桂兴, 黄柳杨, 等. 针灸治疗支气管哮喘的系统评价再评价. 中国循证医学杂志, 2022, 22(8): 955-963.
23.	Yang K, Liu Y, Yuan J. Re-evaluation of systematic reviews in development and improvement. Chin J Evid Ped, 2011, 6(1): 54-57.
24.	欧阳嘉慧, 张淼, 王娅, 等. 中药治疗心力衰竭合并心律失常的系统评价再评价. 时珍国医国药, 2021, 32(5): 1272-1276.
25.	王虎城, 杨丰文, 庞稳泰, 等. 参附注射液治疗心力衰竭的系统评价再评价. 中国中医急症, 2020, 29(1): 41-45,57.

1. 中国中西医结合学会心血管疾病专业委员会, 中国医师协会中西医结合医师分会心血管疾病专业委员会. 慢性心力衰竭中西医结合诊疗专家共识. 心脑血管病防治, 2016, 16(5): 340-347.
2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint Committee on Clinical Practice Guidelines. Circulation, 2022, 145(18): e876-e894.
3. 褚延斌, 苏小琴, 李德坤, 等. 基于一测多评法对注射用益气复脉(冻干)中9种成分的质量控制研究. 中草药, 2017, 48(17): 3537-3544.
4. 孟静, 鲁晓燕. 注射用益气复脉(冻干)治疗心力衰竭的药理作用及临床应用研究进展. 药物评价研究, 2020, 43(8): 1506-1509.
5. 鞠爱春, 罗瑞芝, 苏小琴, 等. 注射用益气复脉(冻干)化学成分及质量控制研究进展. 药物评价研究, 2018, 41(3): 365-371.
6. 鞠爱春, 罗瑞芝, 秦袖平, 等. 注射用益气复脉(冻干)药理作用及临床研究进展. 药物评价研究, 2018, 41(3): 354-364.
7. Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 2021, 372: n160.
8. 陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具AMSTAR 2解读. 中国循证医学杂志, 2018, 18(1): 101-108.
9. 吴琼芳, 丁泓帆, 邓围, 等. ROBIS: 评估系统评价偏倚风险的新工具. 中国循证医学杂志, 2015, 15(12): 1454-1457.
10. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
11. 连宝涛, 李泽彰, 陈嘉城, 等. 益气复脉注射液治疗心力衰竭的系统评价. 中国实验方剂学杂志, 2016, 22(8): 215-220.
12. 王贤良, 马宁, 侯雅竹, 等. 注射用益气复脉(冻干)联合西药常规治疗慢性心力衰竭疗效的Meta分析. 中医杂志, 2016, 57(5): 391-395.
13. 周丽, 范芳芳, 帕提古丽·阿卜杜力, 等. 益气复脉注射液治疗心力衰竭有效性和安全性的Meta分析. 中国医药导报, 2016, 13(22): 93-96,104.
14. 熊尧, 徐程, 陈嘉音, 等. 注射用益气复脉(冻干)治疗心力衰竭的Meta分析. 沈阳药科大学学报, 2017, 34(5): 428-435.
15. 谢娜, 戴小华. 注射用益气复脉(冻干)治疗心力衰竭疗效的Meta分析. 中西医结合心脑血管病杂志, 2019, 17(10): 1499-1503.
16. Nie H, Li S, Liu M, et al. Yiqi Fumai injection as an adjuvant therapy in treating chronic heart failure: a meta-analysis of 33 randomized controlled trials. Evid Based Complement Alternat Med, 2020, 2020: 1876080.
17. 樊根豪, 邢作英, 刘梦琳, 等. 注射用益气复脉(冻干)治疗心力衰竭有效性及安全性的系统评价和试验序贯分析. 实用中医内科杂志, 2021, 35(1): 8-18.
18. 周国锋, 李媛, 林芮, 等. 中药注射剂治疗心力衰竭系统评价再评价. 中华中医药学刊, 2019, 37(1): 125-129.
19. 陈炜坚, 陈慕镟, 林挺, 等. 中药注射剂治疗心律失常的系统评价再评价. 中国医院药学杂志, 2020, 40(23): 2445-2452.
20. 黄帆, 赵思怡, 戴琳, 等. 运用雷达图对针灸治疗原发性骨质疏松症的系统评价再评价. 中国循证医学杂志, 2019, 19(5): 602-608.
21. 杨继, 张垚, 高晟玮, 等. 麝香保心丸治疗冠心病心绞痛系统评价的再评价. 中国中医急症, 2021, 30(5): 785-789.
22. 刘亦琳, 徐桂兴, 黄柳杨, 等. 针灸治疗支气管哮喘的系统评价再评价. 中国循证医学杂志, 2022, 22(8): 955-963.
23. Yang K, Liu Y, Yuan J. Re-evaluation of systematic reviews in development and improvement. Chin J Evid Ped, 2011, 6(1): 54-57.
24. 欧阳嘉慧, 张淼, 王娅, 等. 中药治疗心力衰竭合并心律失常的系统评价再评价. 时珍国医国药, 2021, 32(5): 1272-1276.
25. 王虎城, 杨丰文, 庞稳泰, 等. 参附注射液治疗心力衰竭的系统评价再评价. 中国中医急症, 2020, 29(1): 41-45,57.

Chinese Journal of Evidence-Based Medicine

Yiqi Fumai injection in the treatment of chronic heart failure: an overview of systematic reviews

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content